Scientific Online Resource System

Varna Medical Forum

ANALYSIS OF MORBIDITY AND TREATMENT OF BRONCHIAL ASTHMA IN CHILDREN

A. Tsvetanova , A. Todorova , D. Dimitrov , D. Dimitrova , H. Angelova , P. Parushjeva , D. Dragneva

Abstract


Bronchial asthma is a chronic lung inflammation. This is the most widespread and socially significant disease among non-infectious diseases. Its treatment is expensive and long-lasting. In case of inadequate management, in advancing age and progression of bronchial asthma, its treatment becomes increasingly expensive and ineffective. This often results in hospitalization and disability. Direct and indirect economic costs are related to economic losses estimated at 17,7 billion Euros per year in Europe. It is assumed that about 5% of adults and from 7% to 10% of children suffer from bronchial asthma. The disease manifests at all ages but is more common in early life. About half of all cases of bronchial asthma develop in the age of 10 years, and another one-third of cases occur before 40 years of age. In childhood male-to-female ratio is 2:1, which equalizes by 30 years of age. The study analyzes the incidence rate of bronchial asthma among children according to sex, age, frequency of attacks, therapy and side effects resulting from it. The social aspects and problems of asthma patients in the North Eastern Bulgaria are presented. The inquiry was conducted among two groups of respondents: physicians and patients. Two different questionnaires were elaborated targeted at each group. These groups were selected to cover the disease from its first symptoms, which is of utmost importance for its diagnosis and treatment monitoring.



Keywords

bronchial asthma, children, diagnosis, treatment, incidence rate


Refbacks

Font Size


|